Sunzen Biotech on track to return to the black


Top management: Teo (left) and Ching at the group’s headquarter in Shah Alam. They are very positive about Sunzen’s business outlook.

Sunzen Biotech Bhd is on track to break even this year and aims to achieve profitability in 2022, after incurring losses for three years, according to group managing director and CEO Teo Yek Ming.

Teo tells StarBizWeek that in the near term, the group is optimistic about growing profits for its traditional Chinese medicine, herbal health foods and beverages and bird’s nest segment as well as the recently acquired small and medium enterprise loan financing unit.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Doubling down on productivity
Towards a true Silicon Valley
Growth holds, risks loom
MISC’s RM3bil Yinson gamble
Ringgit expected to trade with slight positive bias next week
118 Mall celebrates year-end festivities with the Living Storybook
Timber's new twist
Coach, Ralph Lauren defy China slump�
Malaysia’s 3Q26 property reality check
Old drains and water strains

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read